Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept plus background NSAID in adults with non-radiographic axial spondyloarthritis
2010-020077-16Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in non-radiographic axial spondyloarthritis (nr-axSpA) and axial spondyloarthritis (axSpA) comparing Etanercept + background NSAID with Placebo + background NSAID (2 arms). Primary endpoint: ASAS 20 response at Week 12. Started Oct 2010; status: completed.
02
Drugs
etanercept
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on 2010-020077-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020077-16.